American Portfolios Advisors Iterum Therapeutics PLC Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Mar 20, 2023
BUY
$0.19 - $0.36 $380 - $720
2,000 New
2,000 $400,000
Q1 2022

Mar 21, 2023
BUY
$0.31 - $0.45 $620 - $900
2,000 New
2,000 $710,000
Q4 2021

Mar 21, 2023
BUY
$0.39 - $0.74 $780 - $1,480
2,000 New
2,000 $784,000
Q3 2021

Mar 22, 2023
BUY
$0.54 - $2.29 $1,080 - $4,580
2,000 New
2,000 $1.12 Million
Q2 2021

Mar 22, 2023
BUY
$0.97 - $2.39 $1,940 - $4,780
2,000 New
2,000 $4.62 Million

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $15.9M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email